Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06440577

Craving & Decision-Making

Craving is the strong desire for something, such as for substances in drug addiction and food or other activities in everyday life. Recent work suggests craving can influence how people make decisions and assign value to choice options available to them, yet the neural mechanisms underlying these interactions between craving and valuation remain unknown. To address this, this study uses cognitive decision-making tasks that measure how much individuals will pay (from a study endowment) to have everyday consumer items or snack foods when they crave something specific (opioids or a specific snack, respectively). First, the study will identify the neural mechanisms for how drug craving (craving for opioids) interacts with valuation for consumer items that have associations with drug use or not in people receiving treatment for opioid use disorder (OUD). This will be evaluated in the activity patterns and interactions among brain regions involved in craving and value assignment during decision-making. Then, the study will examine for parallel mechanisms for how food craving (craving for a specific snack) interacts with valuation for snack food items that have similar features to the craved snack or not in people receiving treatment for OUD and non-psychiatric community control participants.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rutgers, The State University of New Jersey

Piscataway, New Jersey, 08854, United States

Location status: Recruiting

Location contact

Anna Konova, PhD

CONTACT

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • Willingness to follow study requirements, as evidenced by an ability to provide written informed consent and read, understand, and complete the study procedures
  • Minimum of 6th grade reading level

Additional inclusion criteria for participants with OUD:

  • Primary diagnosis of OUD encompassing heroin and/or painkiller use
  • Receiving medications for OUD treatment on an outpatient basis
  • At least 12-month history of opioid use

Exclusion criteria

  • Unable to speak or read English
  • Active psychosis or mania
  • Current or past schizophrenia diagnosis
  • History of intellectual disability or developmental or neurological disorder, seizures or epilepsy, or loss consciousness lasting more than 30 minutes
  • Severe medical conditions requiring hospitalization or that, in the opinion of the study staff could compromise study participation
  • MRI contraindications (claustrophobia, nonremovable piercings, certain metal in the body etc.) or pregnancy

Additional exclusion criteria for community control participants:

  • Positive urine drug screen
  • Current or past problematic substance use other than nicotine, and alcohol abuse confined to college or military service
  • Current or past bipolar disorder diagnosis
  • Use of central nervous system medications within the past 6 weeks (e.g., antidepressants, Ritalin)

Treatment and study plan

Audio-visual stimuli (Neutral-Relaxing)

Behavioral

Audio instruction for participant to allow themselves to experience their feelings followed by 3-min passive viewing of images of neutral everyday objects (e.g., tools, dirt) and their use (construction, gardening).

Audio-visual stimuli (Drug)

Behavioral

Audio instruction for participant to allow themselves to experience their feelings followed by 3-min passive viewing of images of drug paraphernalia (e.g., syringe, tourniquet, heroin) and preparation.

Audio-visual stimuli (Non-Food)

Behavioral

Audio instruction for participant to focus their attention on the experimenter followed by 3-min audio-guided viewing of the experimenter opening/unwrapping an everyday object (e.g., box of crayons) and taking out its contents.

Audio-visual stimuli (Food)

Behavioral

Audio instruction for participant to focus their attention on the experimenter followed by 3-min audio-guided viewing of the experimenter opening/unwrapping a snack (e.g., chocolate bar, bag of chips) and taking out its contents.

Primary outcomes

  1. Willingness-to-pay

    Time frame: during the task

    The amount that a participant would be willing to pay for different available choice options. This is measured during the decision-making tasks in which participants are shown images of consumer items or snack foods and report how much they would be willing to pay to have the different items in that moment.

  2. fMRI-BOLD activity measured during willingness-to-pay decisions

    Time frame: during the task

    Functional MRI data will be analyzed to measure changes in blood-oxygen-level-dependent (BOLD) signal in specific regions of interest based on prior research (ventral striatum, ventromedial prefrontal cortex, amygdala, and insula) as participants make willingness-to-pay decisions during each task.

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Konova, PhD

CONTACT

[email protected]

732-235-4335

Sponsors and collaborators

Lead sponsor

Rutgers, The State University of New Jersey

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Decision Neuroscience of Craving

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jun 4, 2024
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.